Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib
Saumya Jayakumar, Michael S. Middleton, Eric Lawitz, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 1, pp. 133-141
Open Access | Times Cited: 180

Showing 26-50 of 180 citing articles:

Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Elke Roeb, Ali Canbay, Frank Tacke, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. 1346-1421
Open Access | Times Cited: 53
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Ajay Duseja, Shivaram Prasad Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 13, Iss. 2, pp. 273-302
Open Access | Times Cited: 47
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13320-13320
Open Access | Times Cited: 38
Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review
Weon Jang, Ji Soo Song
Diagnostics (2023) Vol. 13, Iss. 11, pp. 1852-1852
Open Access | Times Cited: 27
Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 40-40
Open Access | Times Cited: 13
Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease
Veeral Ajmera, Amy Liu, Seema Singh, et al.
Hepatology (2019) Vol. 71, Iss. 3, pp. 849-860
Open Access | Times Cited: 72
MR elastography‐based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study
Ma Ai Thanda Han, Aarshi Vipani, Nabil Noureddin, et al.
Liver International (2020) Vol. 40, Iss. 9, pp. 2242-2251
Closed Access | Times Cited: 65
Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis
Neeta B. Amin, Santos Carvajal‐Gonzalez, Julie J. Purkal, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 520
Open Access | Times Cited: 64
Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease
Michelle T. Long, Sanil Gandhi, Rohit Loomba
Metabolism (2020) Vol. 111, pp. 154259-154259
Open Access | Times Cited: 60
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
Byung‐Wan Lee, Yong‐ho Lee, Cheol‐Young Park, et al.
Diabetes & Metabolism Journal (2020) Vol. 44, Iss. 3, pp. 382-382
Open Access | Times Cited: 58
Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis
Yali Qu, Mou Li, Gavin Hamilton, et al.
European Radiology (2019) Vol. 29, Iss. 10, pp. 5180-5189
Closed Access | Times Cited: 56
Liver fat quantification: where do we stand?
Jitka Starekova, Scott B. Reeder
Abdominal Radiology (2020) Vol. 45, Iss. 11, pp. 3386-3399
Open Access | Times Cited: 56
Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial
David J. Kazierad, Kristin Chidsey, Veena Somayaji, et al.
Med (2021) Vol. 2, Iss. 7, pp. 800-813.e3
Open Access | Times Cited: 50
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
Life (2021) Vol. 11, Iss. 2, pp. 143-143
Open Access | Times Cited: 45
Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
Kai Zhu, Rohan Kakkar, Daljeet Chahal, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 37, pp. 5327-5338
Open Access | Times Cited: 19
Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk
Tianyi Xia, Mulong Du, Huiqin Li, et al.
Radiology (2023) Vol. 309, Iss. 1
Closed Access | Times Cited: 16
Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis
Fernando Bril, Diana Barb, Romina Lomonaco, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 3, pp. 401-410
Open Access | Times Cited: 51
Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD
Viera Kupčová, Michaela Fedelešová, J Bulas, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 19, pp. 3570-3570
Open Access | Times Cited: 50
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
Mithun Sharma, Madhumita Premkumar, Anand V. Kulkarni, et al.
Journal of Clinical and Translational Hepatology (2020) Vol. 000, Iss. 000, pp. 1-11
Open Access | Times Cited: 49
Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction
Junzhao Ye, Yanqin Wu, Fuxi Li, et al.
Therapeutic Advances in Gastroenterology (2019) Vol. 12, pp. 175628481987904-175628481987904
Open Access | Times Cited: 45
Multiparametric ultrasound imaging for the assessment of normal versus steatotic livers
Lokesh Basavarajappa, Jihye Baek, Shreya Reddy, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort
Kento Imajo, Louise Ann Tetlow, Andrea Dennis, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 7, pp. 609-623
Open Access | Times Cited: 38
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)
Olga Lavynenko, Muhammad Abdul‐Ghani, Mariam Alatrach, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 5, pp. 899-907
Closed Access | Times Cited: 27
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
Terry Cheuk‐Fung Yip, Fei Lyu, Huapeng Lin, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S171-S183
Open Access | Times Cited: 25
Litchi-Derived Polyphenol Alleviates Liver Steatosis and Gut Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blinded, Placebo-Controlled Study
Thananya Jinato, Maneerat Chayanupatkul, Thasinas Dissayabutra, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2921-2921
Open Access | Times Cited: 23

Scroll to top